Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

17.05USD
2:48pm GMT
Change (% chg)

$0.55 (+3.33%)
Prev Close
$16.50
Open
$16.65
Day's High
$17.15
Day's Low
$16.65
Volume
22,080
Avg. Vol
274,751
52-wk High
$22.70
52-wk Low
$4.05

Latest Key Developments (Source: Significant Developments)

Abeona Q3 loss per share $0.13
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Abeona Therapeutics Inc :Abeona reports third quarter 2017 financial results and recent business highlights.Q3 loss per share $0.13.Q3 revenue $219,000 versus I/B/E/S view $220,000.Q3 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S.  Full Article

Abeona Therapeutics prices offering of five million shares at $16 per share
Tuesday, 17 Oct 2017 

Oct 16 (Reuters) - Abeona Therapeutics Inc :Announces pricing of public offering of common stock.Pricing underwritten public offering of five million shares of common stock at a public offering price of $16.00 per share​.  Full Article

Abeona Therapeutics announces public offering of common stock
Monday, 16 Oct 2017 

Oct 17 (Reuters) - Abeona Therapeutics Inc :Abeona Therapeutics announces public offering of common stock.  Full Article

Abeona Therapeutics to receive $13.85 mln of grants for development of Sanfilippo gene therapy programs​
Monday, 16 Oct 2017 

Oct 16 (Reuters) - Abeona Therapeutics Inc :Abeona Therapeutics Inc - ‍nine global foundations collaborate to grant $13.85 million for continued advancement of lead Sanfilippo gene therapy programs​.  Full Article

Abeona Therapeutics enrolls first two patients in phase 1/2 clinical trial in MPS IIIA
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Abeona Therapeutics Inc : :Abeona Therapeutics enrolls first two patients in pivotal expansion of phase 1/2 clinical trial in MPS IIIA.Says to ‍report additional clinical data in ABO-102 global trial later this year​.  Full Article

Viking Global Investors reports 5.6 percent passive stake in Abeona Therapeutics
Monday, 2 Oct 2017 

Oct 2 (Reuters) - Abeona Therapeutics Inc :Viking Global Investors Lp reports 5.6 percent passive stake in Abeona Therapeutics Inc ‍​as of Sept 22 - SEC filing.  Full Article

Abeona Therapeutics Q2 loss per share $0.21
Tuesday, 15 Aug 2017 

Aug 15 (Reuters) - Abeona Therapeutics Inc :Abeona Therapeutics reports second quarter 2017 financial results and recent business highlights.Q2 loss per share $0.21.Q2 revenue $217,000 versus I/B/E/S view $230,000.Q2 earnings per share view $-0.15 -- Thomson Reuters I/B/E/S.  Full Article

Abeona Therapeutics announces Fast Track Designation from FDA for ABO-102 in Sanfilippo Syndrome Type A
Tuesday, 25 Oct 2016 

Abeona Therapeutics Inc :Abeona Therapeutics announces Fast Track Designation from FDA for ABO-102 in Sanfilippo Syndrome Type A.  Full Article

Abeona Therapeutics enters into an at market issuance sales agreement with FBR capital markets & Co, others
Friday, 26 Aug 2016 

Abeona Therapeutics Inc : On August 26, Co entered into an at market issuance sales agreement with FBR capital markets & co and others - sec filing .May sell through agents shares of co, par value $0.01 per share with an aggregate sales price of up to $75 million.  Full Article

Abeona Therapeutics Q2 loss per share $0.20
Tuesday, 16 Aug 2016 

Abeona Therapeutics Inc :Loss per share was $0.20 for q2 of 2016.  Full Article

BRIEF-Abeona Q3 loss per share $0.13

* Abeona reports third quarter 2017 financial results and recent business highlights